“Explore FDA guidance on evaluating multiple versions of cellular and gene therapies in early-phase trials. Learn about IND submission efficiency and CBER’s umbrella trial approach.”
“Learn how CBER oversees cellular and gene therapy approvals, ensuring safety, efficacy, and innovation in life sciences. Discover the future of molecular medicine.” We will
“Learn how Corrective and Preventive Action (CAPA) in medical devices drives quality, compliance, and patient safety. Explore CAPA process under Title 21 CFR Part 820.”
“Explore the balance between innovation and regulation in life sciences, from gene therapies to precision medicine, and how they can coexist to drive progress safely.”
“Learn how BioBoston Consulting helps organizations bridge quality gaps, achieve regulatory excellence, and maintain compliance in biotech, pharma, and medical devices.” Let us guide you
“Learn how to meet FDA cGMP laboratory control requirements for pharmaceutical testing, including sampling, sterility testing, validation of test methods, and quality control in drug
“Learn about FDA cGMP regulations for automatic, mechanical, and electronic equipment used in drug manufacturing. Ensure compliance with calibration, inspection, and documentation requirements.” It is
“Learn how pharmaceutical manufacturers can achieve compliance with FDA cGMP regulations, ensuring safety, quality, and efficacy in drug production.” The pharmaceutical industry is formally regulated
Learn about CFR 21 PART 211 Subpart C regulations for drug manufacturing facilities, covering design, maintenance, utilities, and equipment compliance. The Code of Federal Regulations